Craig Hettenbach
Stock Analyst at Morgan Stanley
(2.70)
# 1,910
Out of 5,150 analysts
307
Total ratings
58.04%
Success rate
-0.47%
Average return
Main Sectors:
Stocks Rated by Craig Hettenbach
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Maintains: Equal-Weight | $40 → $21 | $16.45 | +27.66% | 5 | Feb 25, 2026 | |
| VEEV Veeva Systems | Upgrades: Equal-Weight | $222 → $205 | $188.48 | +8.76% | 10 | Feb 17, 2026 | |
| GDRX GoodRx Holdings | Maintains: Equal-Weight | $5 → $4 | $2.18 | +83.49% | 3 | Dec 18, 2025 | |
| AMWL American Well | Maintains: Equal-Weight | $11 → $6 | $5.46 | +9.89% | 6 | Dec 18, 2025 | |
| HCA HCA Healthcare | Downgrades: Underweight | $425 | $544.41 | -21.93% | 5 | Dec 15, 2025 | |
| ARDT Ardent Health | Downgrades: Equal-Weight | $22 → $12 | $9.64 | +24.48% | 3 | Nov 14, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $57 → $67 | $45.71 | +46.58% | 3 | Sep 23, 2025 | |
| SLAB Silicon Laboratories | Maintains: Equal-Weight | $157 → $144 | $203.58 | -29.27% | 15 | Aug 6, 2025 | |
| OMDA Omada Health | Initiates: Overweight | $25 | $13.52 | +84.91% | 1 | Jul 1, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $175 → $210 | $244.80 | -14.22% | 3 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $200 | $202.31 | -1.14% | 1 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $9 → $5 | $1.22 | +309.84% | 12 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $96 → $114 | $56.28 | +102.56% | 24 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $57 | $34.95 | +63.09% | 19 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $81 | $69.90 | +15.88% | 23 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $35 | $26.44 | +32.38% | 4 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $15.05 | +19.60% | 4 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $208 → $185 | $79.46 | +132.82% | 23 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $162 → $167 | $209.02 | -20.10% | 23 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $42 | $132.75 | -68.36% | 25 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $159 | $208.45 | -23.72% | 2 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $125 | $80.57 | +55.14% | 3 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $72 | $317.53 | -77.23% | 22 | Dec 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $193 → $195 | $202.39 | -3.65% | 3 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $488 | $291.96 | +67.15% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $297 → $296 | $150.04 | +97.28% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $273 → $368 | $280.85 | +31.03% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $513 | $183.11 | +180.16% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $275 | $284.74 | -3.42% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $88 | $44.99 | +95.60% | 1 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | n/a | $62.53 | - | 11 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $173 → $185 | $77.03 | +140.17% | 2 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $190 → $213 | $216.37 | -1.56% | 19 | Apr 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $53 → $58 | $112.74 | -48.55% | 12 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $101 → $117 | $341.51 | -65.74% | 15 | Jun 16, 2020 |
Hims & Hers Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $40 → $21
Current: $16.45
Upside: +27.66%
Veeva Systems
Feb 17, 2026
Upgrades: Equal-Weight
Price Target: $222 → $205
Current: $188.48
Upside: +8.76%
GoodRx Holdings
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.18
Upside: +83.49%
American Well
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $11 → $6
Current: $5.46
Upside: +9.89%
HCA Healthcare
Dec 15, 2025
Downgrades: Underweight
Price Target: $425
Current: $544.41
Upside: -21.93%
Ardent Health
Nov 14, 2025
Downgrades: Equal-Weight
Price Target: $22 → $12
Current: $9.64
Upside: +24.48%
Hinge Health
Sep 23, 2025
Maintains: Overweight
Price Target: $57 → $67
Current: $45.71
Upside: +46.58%
Silicon Laboratories
Aug 6, 2025
Maintains: Equal-Weight
Price Target: $157 → $144
Current: $203.58
Upside: -29.27%
Omada Health
Jul 1, 2025
Initiates: Overweight
Price Target: $25
Current: $13.52
Upside: +84.91%
Tenet Healthcare
Jun 9, 2025
Maintains: Overweight
Price Target: $175 → $210
Current: $244.80
Upside: -14.22%
Mar 26, 2025
Initiates: Equal-Weight
Price Target: $200
Current: $202.31
Upside: -1.14%
Aug 6, 2024
Maintains: Equal-Weight
Price Target: $9 → $5
Current: $1.22
Upside: +309.84%
Feb 7, 2023
Maintains: Equal-Weight
Price Target: $96 → $114
Current: $56.28
Upside: +102.56%
Jun 10, 2022
Maintains: Overweight
Price Target: $62 → $57
Current: $34.95
Upside: +63.09%
Jun 10, 2022
Maintains: Overweight
Price Target: $85 → $81
Current: $69.90
Upside: +15.88%
May 18, 2022
Maintains: Equal-Weight
Price Target: $55 → $35
Current: $26.44
Upside: +32.38%
Mar 28, 2022
Maintains: Overweight
Price Target: $20 → $18
Current: $15.05
Upside: +19.60%
Feb 3, 2022
Maintains: Overweight
Price Target: $208 → $185
Current: $79.46
Upside: +132.82%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $162 → $167
Current: $209.02
Upside: -20.10%
Jan 27, 2022
Maintains: Equal-Weight
Price Target: $42 → $42
Current: $132.75
Upside: -68.36%
Dec 17, 2021
Maintains: Equal-Weight
Price Target: $165 → $159
Current: $208.45
Upside: -23.72%
Dec 13, 2021
Maintains: Overweight
Price Target: $115 → $125
Current: $80.57
Upside: +55.14%
Dec 10, 2021
Maintains: Overweight
Price Target: $57 → $72
Current: $317.53
Upside: -77.23%
Oct 27, 2021
Maintains: Underweight
Price Target: $193 → $195
Current: $202.39
Upside: -3.65%
Aug 31, 2021
Maintains: Overweight
Price Target: $515 → $488
Current: $291.96
Upside: +67.15%
Aug 31, 2021
Maintains: Overweight
Price Target: $297 → $296
Current: $150.04
Upside: +97.28%
Aug 31, 2021
Maintains: Overweight
Price Target: $273 → $368
Current: $280.85
Upside: +31.03%
Aug 31, 2021
Maintains: Overweight
Price Target: $500 → $513
Current: $183.11
Upside: +180.16%
Aug 31, 2021
Maintains: Overweight
Price Target: $321 → $275
Current: $284.74
Upside: -3.42%
Aug 31, 2021
Maintains: Overweight
Price Target: $94 → $88
Current: $44.99
Upside: +95.60%
Aug 3, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $62.53
Upside: -
May 7, 2021
Maintains: Overweight
Price Target: $173 → $185
Current: $77.03
Upside: +140.17%
Apr 8, 2021
Downgrades: Equal-Weight
Price Target: $190 → $213
Current: $216.37
Upside: -1.56%
Feb 11, 2021
Maintains: Equal-Weight
Price Target: $53 → $58
Current: $112.74
Upside: -48.55%
Jun 16, 2020
Maintains: Equal-Weight
Price Target: $101 → $117
Current: $341.51
Upside: -65.74%